Albertine Donker

General Discussion 327 9 al. X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation. The Journal of clinical investigation. 2015;125(4):1665-1669. 20. Khuong-Quang DA, Schwartzentruber J, Westerman M, et al. Iron refractory iron deficiency anemia: presentation with hyperferritinemia and response to oral iron therapy. Pediatrics. 2013;131(2):e620-625. 21. Barron R, Grace ND, Sherwood G, Powell LW. Iron overload complicating sideroblastic anemia--is the gene for hemochromatosis r e s pon s i b l e? Ga s t r oen t e r o l og y. 1989;96(4):1204-1206. 22. Time Journal. 12 March 2009. http://con- tent.time.com/time/specials/packages/arti- cle/0,28804,1884779_1884782_1884766,00. html. Accessed 23 October 2019. 23. Kinkorova J. Biobanks in the era of personalized medicine: objectives, challenges, and innovation: Overview. The EPMA journal. 2015;7:4. 24 Kinkorova J, Topolcan O. Biobanks in Horizon 2020: sustainability and attractive perspectives. The EPMA journal. 2018;9(4):345-353. 25. De Falco L, Sanchez M, Silvestri L, et al. Iron refractory iron deficiency anemia. Haematologica. 2013;98(6):845-853. 26. De Falco L, Silvestri L, Kannengiesser C, et al. Functional and clinical impact of novel TMPRSS6 variants in iron-refractory iron- deficiency anemia patients and genotype- phenotype studies. Human mutation. 2014;35(11):1321-1329. 27. Wang CY, Meynard D, Lin HY. The role of TMPRSS6/matriptase-2 in iron regulation and anemia. Frontiers in pharmacology. 2014;5:114. 28. Finberg KE, Heeney MM, Campagna DR, et al. Mutations in TMPRSS6 cause iron- refractory iron deficiency anemia (IRIDA). Nature genetics. 2008;40(5):569-571. 29. Clark MA, Goheen MM, Fulford A, et al. Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum. Nature communications. 2014;5:4446. 30. Goheen MM, Wegmuller R, Bah A, et al. Anemia Offers Stronger Protection Than Sickle Cell Trait Against the Erythrocytic Stage of Falciparum Malaria and This Protection Is Reversed by Iron Supplementation. EBioMedicine. 2016;14:123-130. 31. Goheen MM, Bah A, Wegmuller R, et al. Host iron status and erythropoietic response to iron supplementation determines susceptibility to the RBC stage of falciparum malaria during pregnancy. Scientific reports. 2017;7(1):17674. 32. Nemeth E. Hepcidin and beta-thalassemia major. Blood. 2013;122(1):3-4. 33. Origa R, Cazzola M, Mereu E, et al. Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and beta- thalassemia intermedia. Haematologica. 2015;100(5):e169-171. 34. Guimaraes JS, Cominal JG, Silva-Pinto AC, et al. Altered erythropoiesis and iron metabolism in carriers of thalassemia. European journal of haematology. 2015;94(6):511-518. 35. Nai A, Pagani A, Silvestri L, Camaschella C. Increased susceptibility to iron deficiency of Tmprss6-haploinsufficient mice. Blood. 2010;116(5):851-852. 36. Gardenghi S, Ramos P, Marongiu MF, et al. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta- thalassemic mice. The Journal of clinical investigation. 2010;120(12):4466-4477. 37. Ginzburg Y, Rivella S. beta-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood. 2011;118(16):4321-4330. 38. Parelsnoer Institute. https://parelsnoer.org/ page/nl/. Accessed 23 October 2019. 39. Manders P, Siezen AE, Gazzoli S, Smit C, Swinkels DW, Zielhuis GA. Radboud Biobank: a central facility for prospective clinical biobanking in the Radboud university medical center, Nijmegen. OA Epidemiology 2014 Feb 10;2(1):4. 40. Manders P, Peters TMA, Siezen AE, et